Sharekhan

Astec Lifesciences Ltd

Fri 31/10/2025,15:50:36 | NSE : ASTEC

₹ 660.05-1.40 (-0.21%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 656.00

Previous Close

₹ 661.45

Volume

25739

Mkt Cap ( Rs. Cr)

₹1470.70

High

₹ 663.15

Low

₹ 655.00

52 Week High

₹ 1217.12

52 Week Low

₹ 655.00

Book Value Per Share

₹ 212.00

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Astec Lifesciences Ltd

Your Vote -

Buy

62.50%

Hold

25.00%

Sell

12.50%

62.50%

16 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Astec Lifesciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Astec Lifesciences L - Copy of Newspaper Publication

    30 Oct 2025, 7:25PM Astec LifeSciences Limited has informed the Exchange about Copy of Newspaper Publication
  • Astec Lifesciences L - Press Release

    30 Oct 2025, 12:39PM Astec LifeSciences Limited has informed the Exchange regarding a press release dated October 29, 2025, titled ""Press Release"".
  • Astec Lifesciences L - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    29 Oct 2025, 10:07PM Please find attached Monitoring Agency Report.
  • Astec Lifesciences L - Monitoring Agency Report

    29 Oct 2025, 9:34PM Monitoring Agency Report
  • Astec Lifesciences L - Statement Of Deviation And Variation For The Quarter And Half- Year Ended September 30, 2025

    29 Oct 2025, 9:08PM Please find enclosed statement of Deviation and Variation for the Quarter and Half - year ended September 30, 2025
  • Astec Lifesciences L - Statement of deviation(s) or variation(s) under Reg. 32

    29 Oct 2025, 8:55PM Astec LifeSciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
  • Astec Lifesciences L - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    29 Oct 2025, 7:15PM Please find Media Release for the Quarter and Half- year ended September 30, 2025.
  • Astec Lifesciences L - Financial Result For The Quarter And Half-Year Ended September 30, 2025.

    29 Oct 2025, 7:12PM Please find enclosed Financial results for the quarter and Half - Year ended September 30, 2025.
  • Astec Lifesciences L - Board Meeting Outcome for Revised Outcome

    29 Oct 2025, 7:06PM Revised outcome
  • Astec Lifesciences L - Outcome of Board Meeting

    29 Oct 2025, 6:56PM Astec LifeSciences Limited has informed the Exchange regarding Board meeting held on October 29, 2025.
  • Astec Lifesciences L - Outcome of Board Meeting

    29 Oct 2025, 5:11PM Astec LifeSciences Limited has submitted to the Exchange, the financial results for the Quarter and Half Year ended September 30, 2025.
  • Astec Lifesciences L - Outcome of Board Meeting

    29 Oct 2025, 5:07PM Astec LifeSciences Limited has informed the Exchange regarding Board meeting held on October 29, 2025.
  • Astec Lifesciences L - Financial Result For The Quarter And Half-Year Ended September 30, 2025.

    29 Oct 2025, 5:07PM Please find enclosed Financial Result for the Quarter and half-year ended as September 30, 2025.
  • Astec Lifesciences L posts Q2 net loss of Rs 24.45 cr

    29 Oct 2025, 5:20PM The company reported standalone net loss during the quarter stood at Rs 24.45 crore as compared to net loss of Rs 38.57 crore in the previous year qua
  • Astec Lifesciences L - Board Meeting Outcome for Outcome Of Board Meeting

    29 Oct 2025, 5:04PM Please find enclosed outcome of Board Meeting
  • Astec Lifesciences L - Change In Senior Management Personnel

    24 Oct 2025, 7:15PM Please find attached intimation.
  • Astec Lifesciences L - General Updates

    24 Oct 2025, 6:56PM Astec LifeSciences Limited has informed the Exchange about resignation of Mr. Vivek Ramchandra Thorat, Associate Vice President - Operations, w.e.f. c
  • Astec Lifesciences L - Resignation

    24 Oct 2025, 6:43PM Astec LifeSciences Limited has informed the Exchange regarding resignation of Mr. Vivek Ramchandra Thorat as Associate Vice President-Operations of t
  • Astec Lifesciences L has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    17 Oct 2025, 9:00PM As of September 2025, 72.42% is owned by Indian Promoters and 27.58% by Public. <p align=justify> Top five Promoters holding highest number of shares
  • Astec Lifesciences L - Board Meeting Intimation for Board Meeting Intimation For Approving The Standalone And\r\nConsolidated

    14 Oct 2025, 5:29PM Astec Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2025 ,inter alia, to consider a
  • Astec Lifesciences L - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Oct 2025, 5:08PM Astec LifeSciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Astec Lifesciences L - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Oct 2025, 5:05PM Please find attached compliance certificate under Regulation 74(5) of SEBI (DP) Regulations.
  • Astec Lifesciences L - Copy of Newspaper Publication

    7 Oct 2025, 6:13PM Astec LifeSciences Limited has informed the Exchange about Copy of Newspaper Publication
  • Astec Lifesciences L - Copy of Newspaper Publication

    7 Oct 2025, 6:00PM Astec LifeSciences Limited has informed the Exchange about Copy of Newspaper Publication
  • Astec Lifesciences L - General Updates

    6 Oct 2025, 7:13PM Astec LifeSciences Limited has informed the Exchange regarding notice of Postal Ballot.
  • Astec Lifesciences L - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    6 Oct 2025, 7:11PM Please find attached Intimation regarding dispatch of Postal Ballot Notice.
  • Astec Lifesciences L - General Updates

    3 Oct 2025, 10:04PM Astec LifeSciences Limited has informed the Exchange about General Updates
  • Astec Lifesciences L - Intimation For Seeking Shareholders' Approval For Material Related Party Transactions

    3 Oct 2025, 8:57PM Please find attached, Intimation for seeking Shareholders' approval for material Related Party Transactions.
  • Astec Lifesciences L - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    3 Oct 2025, 8:53PM Please find attached intimation
  • Astec Lifesciences L - Intimation

    3 Oct 2025, 8:49PM Please find attached intimation
  • Astec Lifesciences L - Announcement under Regulation 30 (LODR)-Change in Directorate

    3 Oct 2025, 8:45PM Please find attached intimation regarding re-appointment of Mr. Nandkumar Dhekne & Ms. Anjali Gupte, subject to approval of the Shareholders.
  • Astec Lifesciences L - General Updates

    3 Oct 2025, 8:39PM Astec LifeSciences Limited has informed the Exchange about General Updates
  • Astec Lifesciences L - General Updates

    3 Oct 2025, 8:37PM Astec LifeSciences Limited has informed the Exchange about conduct of Postal Ballot for seeking approval of the Shareholders.
  • Astec Lifesciences L - Related Party Transactions

    3 Oct 2025, 8:33PM Astec LifeSciences Limited has informed regarding disclosure of seeking approval of Shareholders for Material Related Party Transactions to be entered
  • Astec Lifesciences L - General Updates

    3 Oct 2025, 8:30PM Astec LifeSciences Limited has informed the Exchange about re-appointment of Ms. Anjali Gupte, as a Non-Executive & Independent Director of the Compan
  • Astec Lifesciences L - Intimation For Seeking Shareholders' Approval For Material Related Party Transactions

    3 Oct 2025, 8:57PM Please find attached, Intimation for seeking Shareholders' approval for material Related Party Transactions.
  • Astec Lifesciences L - Intimation For Seeking Shareholders' Approval For Material Related Party Transactions

    3 Oct 2025, 8:57PM Please find attached, Intimation for seeking Shareholders' approval for material Related Party Transactions.
  • Astec Lifesciences L - Trading Window

    26 Sep 2025, 10:23PM Astec LifeSciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulation
  • Astec Lifesciences L - Appointment Of Mr. Sunil Kataria And Cessation Of Mr. Balram Singh Yadav.

    29 Aug 2025, 11:40PM Please find enclosed the intimation for appointment of Mr. Sunil Kataria and cessation of Mr. Balram Singh Yadav.
  • Astec Lifesciences L - Appointment Of Mr. Sunil Kataria And Cessation Of Mr. Balram Singh Yadav.

    29 Aug 2025, 11:35PM Please find enclosed the intimation for appointment of Mr. Sunil Kataria and cessation of Mr. Balram Singh Yadav.
  • Astec Lifesciences L - Cessation

    29 Aug 2025, 10:28PM Astec LifeSciences Limited has informed the Exchange regarding Cessation of Mr BalramSingh Yadav as Non- Executive Director of the company w.e.f. Augu
  • Astec Lifesciences L - Appointment

    29 Aug 2025, 10:28PM Astec LifeSciences Limited has informed the Exchange regarding Appointment of Mr Sunil Kataria as Non- Executive Director of the company w.e.f. Septem
  • Astec Lifesciences L - Announcement under Regulation 30 (LODR)-Change in Directorate

    29 Aug 2025, 9:37PM Please find enclosed the Intimation for appointment of Mr. Sunil Kataria and cessation of Mr. Balram Singh
  • Astec Lifesciences L - General Updates

    29 Aug 2025, 9:33PM Astec LifeSciences Limited has informed the Exchange about General Updates
  • Astec Lifesciences L has submitted to BSE the Shareholding Pattern for the Period Ended July 29, 2025

    7 Aug 2025, 3:50PM As of July 2025, 72.42% is owned by Indian Promoters and 27.58% by Public. <p align=justify> Top five Promoters holding highest number of shares of As
  • Astec Lifesciences L - Action(s) taken or orders passed

    1 Aug 2025, 8:06PM Astec LifeSciences Limited has informed the Exchange about Action(s) taken or orders passed
  • Astec Life board approves fund raise of up to Rs. 250 cr via rights issue

    24 Jun 2025 , 11:46AM Board consider and approves the raising of funds through rights issue of equity shares

Key fundamentals

Evaluate the intrinsic value of Astec Lifesciences Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 788.618 862.5712 759.9738 675.3541 495.7336
Liabilities 788.618 862.5712 759.9738 675.3541 495.7336
Equity 19.6114 19.6092 19.6057 19.5976 19.5876
Gross Profit -66.1953 -5.9027 76.265 154.0835 111.5063
Net Profit -134.8082 -46.9871 25.5204 89.818 64.6925
Cash From Operating Activities -8.39 10.1314 74.3232 23.412 -8.0619
NPM(%) -35.35 -10.25 4.06 13.27 11.65
Revenue 381.3035 458.1807 628.1662 676.5661 554.8721
Expenses 447.4988 464.0834 551.9012 522.4826 443.3658
ROE(%) -28.53 -9.94 5.4 19.01 13.69

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
21 Jul 2023 1.5 15 0 1351.65
19 Jul 2022 1.5 15 0 1950.65
22 Jul 2021 1.5 15 0 1156.65
16 Jul 2020 1.5 15 0 435.35
18 Jul 2019 1.5 15 0 507.05
19 Jul 2018 1.5 15 0 691.25
17 Jul 2017 1.5 15 0 596.25
15 Sep 2015 1.25 12.5 0 165.5
15 Sep 2014 1 10 0 43.3
02 Sep 2013 0.75 7.5 0 18.55
13 Sep 2012 0.5 5 0 25.05
15 Sep 2011 0.5 5 0 46.8
12 Aug 2010 1 10 0 57.35

Peers

Other companies within the same industry or sector that are comparable to Astec Lifesciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 849.90 0.68 77.05 376.59 301.39 0.59
Lotus Eye Hospital and Institute Ltd 125.03 3.06 403.32 1372.24 3.55 0.00
Vaishali Pharma Ltd 10.04 -0.30 334.67 8608.54 3.13 0.00
Suraksha Diagnostic Ltd 317.95 -1.20 49.76 3436.56 305.53 0.00

Company Info

Our Company was incorporated on January 25, 1994 under the Companies Act, 1956 as Urshila Traders Private Limited. Our Company was originally promoted by Mrs. Reena Bagai and Mrs. Avita Fernandes. Their shareholding was purchased by Mr. Ashok V Hiremath and Mr. Pratap Garud on February 11, 1994. The name of our Company was changed to Astec Chemicals Private Limited on August 19, 1994 and further to Astec LifeSciences Private Limited on March 3, 2006. With effect from April 27, 2006, Astec LifeSciences Private Limited was converted into a public limited company under the name of "Astec LifeSciences Limited". We carry out our manufacturing activities at two locations in Maharashtra, India comprising of three units in Maharashtra viz. one unit at Dombivli and two units at Mahad (Unit 1 and Unit 2). We started our first manufacturing unit in August 1994 by acquiring a sick unit in Dombivli, Maharashtra having an installed capacity of 120 MT for the manufacture of Dicap, a pharmaceutical intermediate. With a view to expand our operations, we entered into an agreement with Behram Chemicals Private Limited on February 18, 2002 for using and operating their manufacturing facilities located at B-16, Mahad Industrial Area, Sub-District Mahad, District Raigad, Maharashtra. Behram Chemicals Private Limited was engaged in manufacture of chemicals and pesticides having an installed capacity of 130 MT. Behram Chemicals Private Limited was initially promoted by Mr. Jehangir J. Mistry, Mrs. Villoo J. Mistry, Mrs. Kamla G. Sippy and Mr. Surinder Kumar Verma in April, 1993. During August, 1998 further shares were allotted to M.C. Chemicals and some members of Gangani family viz. Mr. Nasrudin K Gangani, Mr. S. N. Gangani, Mrs. N. N. Gangani, Mr. T. K. Gangani and Khoja Bone Mills Private Limited (a company promoted by Gangani family). Looking at the potential in Behram Chemicals Private Limited, our Company have acquired 65.63% share by entering into Share Purchase Agreement with the above members of Gangani family on April 2, 2007. Mr. Jehangir J. Mistry, Mrs. Villoo J. Mistry, Mrs. Kamla G. Sippy and Mr. Surinder Kumar Verma, M.C. Chemicals and Gangani family are not related to our Promoters / our Directors in any manner in any capacity whatsoever. With this acquisition, Behram Chemicals Private Limited became a subsidiary of our Company. During 2003-04 we expanded total installed capacity of our units (Dombivli and Mahad) from 250 MT to 500 MT. We renewed the agreement on August 1, 2004 for a further period of 66 months ending on January 31, 2010. For more details in respect of the current agreement. In 2004, we acquired a plot located at B-17, Mahad, Maharashtra and set up a new manufacturing facility as an Export Oriented Unit (EOU) in the year 2005 (as Unit 2) which is located adjacent to Unit 1 with an installed capacity of 1000 MT. With the commissioning of Unit 2 our total installed capacity increased to 1500 MT. We further expanded our total capacities to 2000 MT during 2006- 07 and to 2500 MT during 2007-08. Our Company is primarily involved in the production of active ingredients and intermediates for agrochemicals and pharmaceutical segment. Hexaconazole, Tebuconazole, Metalaxyl and Propiconazole are some of our key products in agrochemical segment which are generally used in crop protection and Dicap is one of our key Pharmaceutical intermediate which is used in manufacture of antifungal agents. Triazole fungicides, which includes Hexaconazole, Tebuconazole, and Propiconazole is one of our major product in the agrochemical segment, and has contributed 63.67% to our total sales whereas Dicap, a key product in pharmaceutical segment has contributed 9.01% during FY 2007-08. Major events of our Company Period Events January 1994 Incorporation of Urshila Traders Private Limited August 1994 Change of name to Astec Chemicals Private Limited August 1994 Commenced first manufacturing unit at Dombivli, Maharashtra May, 2001 Certified ISO 9002 by International Standards Certification Pty Limited, Australia February 2002 Entered into an agreement with Behram Chemicals Private Limited March 2005 Re-certified ISO 9001:2000 by International Standards Certification Pty Limited, Australia May 2005 Commenced another manufacturing unit (Unit 2) as Export Oriented Unit at Mahad, Maharashtra March 2006 Change of name to Astec LifeSciences Private Limited April 2006 Conversion of our Company from a private limited company to a public limited company January 2007 Established Astec Europe in Tournai, Belgium April 2007 Behram Chemicals Private Limited became our subsidiary by acquisition of 65.63% vide Share Purchase Agreement dated April 2, 2007 2011 -Registered Office of the Company has been shifted 5, 5-A, 4th Floor, Kamanwala Chambers, Sir P. M. Road, Fort, Mumbai - 400001 To Elite Square, 7th Floor, 274, Perin Nariman Street, Fort, Mumbai - 400001. 2012 - Astec has entered into an exclusive long term contract with a multinational company to manufacture and supply a fungicide - Astec Recommended a dividend of fifty paise per share (i.e. 5% on the face value of Rs.10/- each) 2013 -Astec Lifesciences Ltd has Recommended a dividend of Seventy Five paise per share (i.e. 7.5% on face value of Rs. 10/- each). -Mr. Ravindra Inani as Chief Financial Officer (CFO) of the Company. 2014 -Appointed Dr. Leena Raje as the new Woman Director. -Astec Lifesciences Ltd has recommend enhanced dividend of Rupee One per share (i.e. 10% on the face value of Rs. 10/- each. 2017 -Astec Lifesciences Ltd was received Certificate of Merit for Performance in Industrial Safety 2017 2018 -Astec Lifesciences Ltd Wins Indian Chemical Council (ICC) Award For Excellence In Management --Astec Lifesciences Ltd amalgametted with Godrej Agrovet Limited 2019 -Astec Lifesciences Ltd was awared ICC Award for Excellence in Human Resource Management 2020 -Astec Lifesciences Ltd is stake entire equity in Astec Europe Sprl 2021 -Astec LifeSciences Limited commenced commercial production at its new Herbicide plant at Mahad 2023 -Astec LifeSciences launches Rs. 100 crore Adi Godrej Center for Chemical Research and Development. -Astec LifeSciences launches R&D Center to develop new crop protection formulations.

Our Company was incorporated on January 25, 1994 under the Companies Act, 1956 as Urshila Traders Private Limited. Our Company was originally promoted by Mrs. Reena Bagai and Mrs. Avita Fernandes. Their shareholding was purchased by Mr. Ashok V Hiremath and Mr. Pratap Garud on February 11, 1994. The name of our Company was changed to Astec Chemicals Private Limited on August 19, 1994 and further to Astec LifeSciences Private Limited on March 3, 2006. With effect from April 27, 2006, Astec LifeSciences Private Limited was converted into a public limited company under the name of "Astec LifeSciences Limited". We carry out our manufacturing activities at two locations in Maharashtra, India comprising of three units in Maharashtra viz. one unit at Dombivli and two units at Mahad (Unit 1 and Unit 2). We started our first manufacturing unit in August 1994 by acquiring a sick unit in Dombivli, Maharashtra having an installed capacity of 120 MT for the manufacture of Dicap, a pharmaceutical intermediate. With a view to expand our operations, we entered into an agreement with Behram Chemicals Private Limited on February 18, 2002 for using and operating their manufacturing facilities located at B-16, Mahad Industrial Area, Sub-District Mahad, District Raigad, Maharashtra. Behram Chemicals Private Limited was engaged in manufacture of chemicals and pesticides having an installed capacity of 130 MT. Behram Chemicals Private Limited was initially promoted by Mr. Jehangir J. Mistry, Mrs. Villoo J. Mistry, Mrs. Kamla G. Sippy and Mr. Surinder Kumar Verma in April, 1993. During August, 1998 further shares were allotted to M.C. Chemicals and some members of Gangani family viz. Mr. Nasrudin K Gangani, Mr. S. N. Gangani, Mrs. N. N. Gangani, Mr. T. K. Gangani and Khoja Bone Mills Private Limited (a company promoted by Gangani family). Looking at the potential in Behram Chemicals Private Limited, our Company have acquired 65.63% share by entering into Share Purchase Agreement with the above members of Gangani family on April 2, 2007. Mr. Jehangir J. Mistry, Mrs. Villoo J. Mistry, Mrs. Kamla G. Sippy and Mr. Surinder Kumar Verma, M.C. Chemicals and Gangani family are not related to our Promoters / our Directors in any manner in any capacity whatsoever. With this acquisition, Behram Chemicals Private Limited became a subsidiary of our Company. During 2003-04 we expanded total installed capacity of our units (Dombivli and Mahad) from 250 MT to 500 MT. We renewed the agreement on August 1, 2004 for a further period of 66 months ending on January 31, 2010. For more details in respect of the current agreement. In 2004, we acquired a plot located at B-17, Mahad, Maharashtra and set up a new manufacturing facility as an Export Oriented Unit (EOU) in the year 2005 (as Unit 2) which is located adjacent to Unit 1 with an installed capacity of 1000 MT. With the commissioning of Unit 2 our total installed capacity increased to 1500 MT. We further expanded our total capacities to 2000 MT during 2006- 07 and to 2500 MT during 2007-08. Our Company is primarily involved in the production of active ingredients and intermediates for agrochemicals and pharmaceutical segment. Hexaconazole, Tebuconazole, Metalaxyl and Propiconazole are some of our key products in agrochemical segment which are generally used in crop protection and Dicap is one of our key Pharmaceutical intermediate which is used in manufacture of antifungal agents. Triazole fungicides, which includes Hexaconazole, Tebuconazole, and Propiconazole is one of our major product in the agrochemical segment, and has contributed 63.67% to our total sales whereas Dicap, a key product in pharmaceutical segment has contributed 9.01% during FY 2007-08. Major events of our Company Period Events January 1994 Incorporation of Urshila Traders Private Limited August 1994 Change of name to Astec Chemicals Private Limited August 1994 Commenced first manufacturing unit at Dombivli, Maharashtra May, 2001 Certified ISO 9002 by International Standards Certification Pty Limited, Australia February 2002 Entered into an agreement with Behram Chemicals Private Limited March 2005 Re-certified ISO 9001:2000 by International Standards Certification Pty Limited, Australia May 2005 Commenced another manufacturing unit (Unit 2) as Export Oriented Unit at Mahad, Maharashtra March 2006 Change of name to Astec LifeSciences Private Limited April 2006 Conversion of our Company from a private limited company to a public limited company January 2007 Established Astec Europe in Tournai, Belgium April 2007 Behram Chemicals Private Limited became our subsidiary by acquisition of 65.63% vide Share Purchase Agreement dated April 2, 2007 2011 -Registered Office of the Company has been shifted 5, 5-A, 4th Floor, Kamanwala Chambers, Sir P. M. Road, Fort, Mumbai - 400001 To Elite Square, 7th Floor, 274, Perin Nariman Street, Fort, Mumbai - 400001. 2012 - Astec has entered into an exclusive long term contract with a multinational company to manufacture and supply a fungicide - Astec Recommended a dividend of fifty paise per share (i.e. 5% on the face value of Rs.10/- each) 2013 -Astec Lifesciences Ltd has Recommended a dividend of Seventy Five paise per share (i.e. 7.5% on face value of Rs. 10/- each). -Mr. Ravindra Inani as Chief Financial Officer (CFO) of the Company. 2014 -Appointed Dr. Leena Raje as the new Woman Director. -Astec Lifesciences Ltd has recommend enhanced dividend of Rupee One per share (i.e. 10% on the face value of Rs. 10/- each. 2017 -Astec Lifesciences Ltd was received Certificate of Merit for Performance in Industrial Safety 2017 2018 -Astec Lifesciences Ltd Wins Indian Chemical Council (ICC) Award For Excellence In Management --Astec Lifesciences Ltd amalgametted with Godrej Agrovet Limited 2019 -Astec Lifesciences Ltd was awared ICC Award for Excellence in Human Resource Management 2020 -Astec Lifesciences Ltd is stake entire equity in Astec Europe Sprl 2021 -Astec LifeSciences Limited commenced commercial production at its new Herbicide plant at Mahad 2023 -Astec LifeSciences launches Rs. 100 crore Adi Godrej Center for Chemical Research and Development. -Astec LifeSciences launches R&D Center to develop new crop protection formulations.

Read More

Parent Organisation

Astec Lifesciences Ltd.

Founded

25/01/1994

Managing Director

Mr.Burjis N Godrej

NSE Symbol

ASTECEQ

FAQ

The current price of Astec Lifesciences Ltd is ₹ 660.05.

The 52-week high for Astec Lifesciences Ltd is ₹ 663.15 and the 52-week low is ₹ 655.00.

The market capitalization of Astec Lifesciences Ltd is currently ₹ 1470.70. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Astec Lifesciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Astec Lifesciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Astec Lifesciences Ltd shares.

The CEO of Astec Lifesciences Ltd is Mr.Burjis N Godrej, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT